AbstractA PCR-SSCP approach was used to search for mutations in IL-6 receptor genes in 9 human plasma cell lines (HMCL) and in tumor plasma cells from 19 patients with fulminating multiple myeloma, an IL-6-related disease. Whereas no mutation was found in the cytokine receptor homologous (CRH) domain of IL-6Rα, DNA and RNA polymorphisms in the gp130 CRH domain was detected in tumoral samples as well as in blood samples from healthy donors. Finally, mutations in the gp130 critical cytoplasmic domain were found in one HMCL and in tumor plasma cells of one patient. Only the mutated allele was expressed in the HMCL
It is well established that interleukin-6 (IL-6) is an essential growth factor for multiple myeloma ...
�� 2016The Authors. Published by Springer Nature. This is an open access article available under a C...
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflam...
AbstractA PCR-SSCP approach was used to search for mutations in IL-6 receptor genes in 9 human plasm...
A PCR-SSCP approach was used to search for mutations in IL-6 receptor genes in 9 human plasma cell l...
The growth and survival of multiple myeloma (MM) cells in the bone marrow microenvironment is regula...
Interleukin-6 (IL-6) is a potent pleiotropic cytokine that regulates plasma cell (PC) growth via the...
AbstractMycloma cells absolutely require interleukin-6 (IL-6) for growing in vivo in patients with m...
Interleukin-6 (IL-6) is a potent pleiotropic cytokine that regulates plasma cell (PC) growth via the...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Background and Objectives. Established human myeloma cell lines (HMCL) have significantly contribute...
It is well established that interleukin-6 (IL-6) is an essential growth factor for multiple myeloma ...
To explore the mechanisms involved in the pathogenesis of human multiple myeloma (MM). we investigat...
We explored the molecular mechanisms involved in the establishement of CMA-03/06, an IL-6-independen...
It is well established that interleukin-6 (IL-6) is an essential growth factor for multiple myeloma ...
�� 2016The Authors. Published by Springer Nature. This is an open access article available under a C...
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflam...
AbstractA PCR-SSCP approach was used to search for mutations in IL-6 receptor genes in 9 human plasm...
A PCR-SSCP approach was used to search for mutations in IL-6 receptor genes in 9 human plasma cell l...
The growth and survival of multiple myeloma (MM) cells in the bone marrow microenvironment is regula...
Interleukin-6 (IL-6) is a potent pleiotropic cytokine that regulates plasma cell (PC) growth via the...
AbstractMycloma cells absolutely require interleukin-6 (IL-6) for growing in vivo in patients with m...
Interleukin-6 (IL-6) is a potent pleiotropic cytokine that regulates plasma cell (PC) growth via the...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Aberrant methylation of tumor suppressor genes (TSG) is an important epigenetic event in cancer, inc...
Background and Objectives. Established human myeloma cell lines (HMCL) have significantly contribute...
It is well established that interleukin-6 (IL-6) is an essential growth factor for multiple myeloma ...
To explore the mechanisms involved in the pathogenesis of human multiple myeloma (MM). we investigat...
We explored the molecular mechanisms involved in the establishement of CMA-03/06, an IL-6-independen...
It is well established that interleukin-6 (IL-6) is an essential growth factor for multiple myeloma ...
�� 2016The Authors. Published by Springer Nature. This is an open access article available under a C...
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflam...